Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Regulus Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Sportradar to Participate in Canaccord Genuity 44th Annual Growth Conference
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 05 08 2024] - (CGWL)
-
Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Passage Bio to Participate in Upcoming Investor Conferences
-
Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference
-
Artivion to Participate in Upcoming Investor Conferences
-
Clover Health Reports Second Quarter 2024 Financial Results; Improves Full-Year Guidance on Strong Performance
-
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Announces Participation in Upcoming Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
-
ChromaDex to Present at Canaccord Genuity’s 44th Annual Growth Conference
-
Lucid Diagnostics to Participate in Upcoming Investor Conferences
-
Bridger Aerospace Announces Schedule for its Second Quarter 2024 Earnings Release and Conference Call
-
Clene to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
-
Touchstone Exploration Inc. Announces Statement Regarding Lease Operators Offer
-
EuroPacific Closes First Tranche of Private Placement
-
Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference
-
Pega to Present at Upcoming Investor Conference
-
Aurora Announces Closing of $483 Million Upsized Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Driven Brands (DRVN) PT Raised to $19 at Canaccord Genuity
-
Compass Pathways (CMPS) PT Lowered to $48 at Canaccord Genuity
-
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Alnylam Pharmaceuticals (ALNY) PT Raised to $366 at Canaccord Genuity
-
Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference
-
ACI Worldwide (ACIW) PT Raised to $60 at Canaccord Genuity
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 01 08 2024] - (CGWL)
-
Valeura Energy Inc. Announces Wassana Production Restart
-
Trupanion to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
-
T2 Biosystems to Attend Upcoming Investor Conferences
-
Arcturus Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference
-
Adicet Bio to Participate in Upcoming Investor Conferences
-
Rupert Resources Closes $28.8 Million Equity Financing
-
Blackline Safety to Participate in 44th Annual Canaccord Genuity Growth Conference
-
Aurora (AUR) Prices 116.67M Share Offering at $3.60/sh
-
Avalyn to Participate in Multiple Upcoming Investor Conferences
-
Aurora Announces Pricing of $420 Million Upsized Public Offering of Class A Common Stock
-
The Beauty Health Company (SKIN) PT Lowered to $2 at Canaccord Genuity
-
Zeta Global Holdings Corp (ZETA) PT Raised to $28 at Canaccord Genuity
-
TransMedics Group (TMDX) PT Raised to $169 at Canaccord Genuity
-
Tenable (TENB) PT Lowered to $53 at Canaccord Genuity
-
Teladoc (TDOC) PT Lowered to $17 at Canaccord Genuity
-
Pulmonx Corp. (LUNG) PT Raised to $16 at Canaccord Genuity
-
BeMetals Closes $4.8 Million Private Placement
-
Enovix Corporation (ENVX) PT Raised to $20 at Canaccord Genuity
-
Bandwidth Announces Second Quarter 2024 Financial Results
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 31 07 2024] - (CGWL)
-
CGI Group Inc (GIB/A:CN) (GIB) PT Raised to Cdn$170 at Canaccord Genuity
-
CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Generac Holdings (GNRC) PT Raised to $200 at Canaccord Genuity

